- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 487/12 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups in which the condensed system contains three hetero rings
Patent holdings for IPC class C07D 487/12
Total number of patents in this class: 191
10-year publication summary
|
5
|
11
|
6
|
7
|
13
|
5
|
12
|
12
|
14
|
10
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Dana-Farber Cancer Institute, Inc. | 2573 |
10 |
| Hydra Biosciences, LLC | 20 |
7 |
| Hoffmann-La Roche Inc. | 3439 |
6 |
| Merck Sharp & Dohme LLC | 3751 |
6 |
| Bristol-myers Squibb Company | 4880 |
5 |
| Agenebio, Inc. | 46 |
5 |
| Intra-Cellular Therapies, Inc. | 410 |
4 |
| F. Hoffmann-La Roche AG | 7947 |
3 |
| The Regents of the University of California | 19961 |
3 |
| Bayer Pharma AG | 1053 |
3 |
| The Johns Hopkins University | 5675 |
3 |
| BeiGene, Ltd. | 369 |
3 |
| Neuron23, Inc. | 25 |
3 |
| Insilico Medicine IP Limited | 128 |
3 |
| Novartis AG | 10744 |
2 |
| Merck Sharp & Dohme Corp. | 2191 |
2 |
| The Board of Trustees of the Leland Stanford Junior University | 6428 |
2 |
| Mitsubishi Chemical Corporation | 4525 |
2 |
| Abbvie Inc. | 1800 |
2 |
| ArQule, Inc. | 135 |
2 |
| Other owners | 115 |